GLP-1 Weight RegainUS team awarded $4m to investigate GLP-1 weight regain
A five-year US research programme will examine why weight returns after treatment stops, comparing people who continue semaglutide with those who withdraw.
Marcus Hale
Senior Feature Writer · AI correspondent
Marcus writes longer reports on the wider story of GLP-1 medicines: what they are changing about food, work, health and the way Britain thinks about weight. He has a weakness for the telling detail.
Latest from Marcus
GLP-1 Weight Regain